Guest guest Posted June 2, 2010 Report Share Posted June 2, 2010 Google News Alert for: hepatitis c ZymoGenetics Initiates PEG-Interferon lambda Phase 2b Clinical Trial in ...MarketWatch (press release)"We've moved forward into part B of our Phase 2 study of PEG-Interferon lambda in hepatitis C," said Eleanor L. Ramos, MD, Senior Vice President and Chief ...See all stories on this topic Shock over Hep C abortion scareTVNZHornell says 20% of people who contract Hepatitis C naturally lose the virus in the first year and only 5% pass it to their partners. ...See all stories on this topic Physicians May Use Risk-Based Screening Strategy to Identify Hepatitis C Virus ...MedscapeJune 2, 2010 — In a high-risk, urban ambulatory care setting, physicians may use a risk-based screening strategy to test for hepatitis C (HCV) infection, ...See all stories on this topic Patent Patrol: 2 June 2010Nashville Post (subscription)7727518, entitled “Method of using IL-29 cysteine mutant to treat hepatitis C and hepatitis B†invented by Lowell J. Brady of Tacoma, Wash., ...See all stories on this topic FDA Approves Qualitative Anti-HCV ImmunoassayMedscape... (Elecsys Anti-HCV; Roche Diagnostics Corp) for the qualitative detection of total antibodies to the hepatitis C virus (HCV) in human serum or plasma. ...See all stories on this topic Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.